Article
SET-PP2A complex as a new therapeutic target in KMT2A (MLL) rearranged AML.
2023-02-16
Abstract excerpt
<h4>Background: </h4> KMT2A -rearranged (KMT2A-R) is an aggressive and chemo-refractory acute leukemia which mostly affects children. Transcriptomics-based characterization and chemical interrogation identified kinases as key drivers of survival and drug resistance in KMT2A -R leukemia. In contrast, the contribution and regulation of phosphatases is unknown. We explored the role of SET, the endogenous inhibitor of...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 8e3d57b0-7add-5e4e-8f96-97bac2d54a40
- DOI
- 10.21203/rs.3.rs-2583091/v1
